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doi:10.1016/j.ejvs.2010.04.014Abstract Background: The nature of the inflammatory change within ruptured AAA has not
been extensively reported. The aim of this study was to compare the inflammatory response
in non-ruptured and ruptured aneurysms with emphasis on the site of rupture.
Methods: Non-rupture site biopsies were taken from the anterior aneurysm sac of non-
ruptured (nZ 31) and ruptured AAA (nZ 20). In 12 ruptured AAA, a further biopsy was taken
from the rupture site. Enzyme-linked immunosorbent assay was used to quantify IL-6, IL-1beta
and TNF-alpha. Quantitative immunohistochemistry was undertaken for generic lymphocytes,
T-cells, and B-cells.
Results: Comparing biopsies in non-ruptured AAA versus a non-rupture site biopsy from
ruptured AAA; there was no significant difference in IL-6, IL-1b, TNF-alpha, generic lympho-
cytes, T-cell or B-cell content. Comparing ruptured AAA e non-rupture site with rupture site;
IL-6 and TNF-alpha were unchanged. By contrast IL-1b and lymphocytes were lower at the
rupture site compared to the non-rupture site (IL-1b 1.39 ng/mg [0.97e2.29] vs. 1.92 ng/mg
[1.46e2.57], pZ 0.027; generic lymphocytes 2.89% [0.51e5.51] vs. 4.73% [2.27e12.40],
pZ 0.018; T-cells 0.28% [0.04e1.18] vs. 0.82% [0.40e1.36], pZ 0.027; B-cells 0.16%
[0.04e1.14] vs. 1.30% [0.32e5.40], pZ 0.021).
Conclusions: These findings suggest the biological events leading to AAA rupture may not be
dependent on an up-regulation in the inflammatory process.
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The abdominal aorta is a complex three layered structure
containing supporting fibres (elastin and collagen) and
cellular components of smooth muscle and mesenchymal
linage. Abdominal aortic aneurysm (AAA) formation is
associated with a change in cellular composition. Cellular
changes are characterised by destruction of the intima, loss
of smooth muscle cells from the media, infiltration of
inflammatory cells and other mesenchymal cells into the
adventitia and deposition of thrombus around the
expanded vessel lumen.1,2 In conjunction with these
cellular changes there is a marked up-regulation of matrix
metalloproteinases (MMP), a group of enzymes which
degrade elastin and collagen.
Inflammation is associated with aneurysmal change in
the abdominal aorta. Inflammation takes two forms; firstly,
inflammatory cells (in all their facets); secondly, inflam-
matory mediators (interleukins and cytokines). Up-regula-
tion of both inflammatory cells and mediators are
extensively reported in aneurysm literature however,
a direct analysis at the site of vessel rupture is lacking.
Furthermore, whilst macrophages and generic lymphocytes
are spatially orientated around neo-vessels at the rupture
site,3 quantitative analysis of these cells fails to show an
increase.4 Rather, generic lymphocytes may be decreased
at the site of aneurysm rupture.4
The study presented here, observes inflammatory
changes in aneurysm biopsies from three distinct sites: 1)
stable non-ruptured aneurysms, 2) a non-ruptured site
within the ruptured aneurysm and 3) the actual site of
aortic aneurysm rupture. The objectives were to further
examine lymphocyte and inflammatory mediator changes
within the wall of ruptured aneurysms.
Methods
Study design
Local research ethics committee approval for the study was
obtained and written consent was given by all patients. Two
patient groups were studied, 31 patients with non-ruptured
AAA (nrAAA) undergoing elective repair, and 20 patients
with ruptured AAA (rAAA) undergoing emergency surgery
(mean age; nrAAA 69 yrsþ/ 4.8, rAAA 71 yrsþ/ 6.7,
pZ 0.465). The maximum external diameter of each non-
ruptured AAA was determined from a pre-operative
computed tomogram. The diameter of each ruptured AAA
was measured intra-operatively (median size and IQR;
nrAAA 6.5 cm (5.1e7), rAAA 8.1 cm (5.9e9.0), pZ 0.011).
Tissue collection
Non-rupture site biopsies of aortic wall were obtained
intra-operatively from the surgical arteriotomy in the
anterior aneurysm wall, 5 cm distal to the left renal vein, in
all non-ruptured and ruptured AAA. An additional biopsy
from the actual site of aneurysm rupture was taken from 12
of the ruptured AAA (the definitive site of rupture could not
be determined in 8 ruptured AAA). No rupture site coin-
cided with the non-rupture site. All biopsies were washed insaline, dissected of luminal thrombus and adipose tissue
then divided in two and frozen in liquid nitrogen or fixed in
4% paraformaldehyde and embedded in paraffin wax.
Cytokine quantification
A protein extract was prepared from the tissues by an
established methodology.5 In brief, frozen aortic biopsies
were thawed then homogenized in a volume of buffer
solution directly proportional to the wet weight of the
aortic biopsy. Following centrifugation (12,000 rpm,
60 min, 4 C) the protein extracted supernatant was dia-
lyzed (overnight, 4 C). The concentration of each protein
extract was then standardized to 1 mg/ml by spectropho-
tometry. Enzyme-linked immunosorbent assay kits (Amer-
sham Pharmacia Biotech, Buckinghamshire, UK) employing
the conventional “sandwich” formats were used to quantify
the cytokines; Interleukin-6 (IL-6), Interleukin-1beta (IL-1b)
and Tumour Necrosis Factor-alpha (TNF-a). The final
concentration of each cytokine was expressed as nano-
grams of target protein per milligram of protein extract.
Histological analysis
Immunohistochemistry
Anterior aneurysm wall biopsies from non-ruptured
(nZ 31) and ruptured AAA (nZ 20) were analysed along
with site of rupture biopsies (nZ 12). Five histological
sections from each biopsy underwent immunohistochem-
istry for generic lymphocytes (CD-45), T-lymphocytes (CD-
3) and B-lymphocytes (CD-20). Histological sections were
dewaxed in xylene and rehydrated through graded alcohols
to water. Antigen retrieval was achieved with 0.1% trypsin
solution in 0.1% calcium chloride, buffered to pH 7.8 (37 C,
12 min). Following addition of the primary antibody for 1 h
at room temperature (either Monoclonal CD-45 [1:50],
Monoclonal CD-3 [1:50] R&D Systems, Minneapolis, Min-
nesota, USA, or Monoclonal CD-20 [1:100] Novocastra
Laboratories, Newcastle upon Tyne, UK), the EnVision
Detection System (EnVision, Dako, Glostrup, Denmark)
was used according to the manufacturers instructions with
washes between each step using phosphate-buffered
saline. Diaminobenzidine (DAB, Dako, Glostrup, Denmark)
at a concentration of 0.05% was added to each slide (room
temperature, 10 min). The sections were then washed in
distilled water, dehydrated in absolute alcohol and moun-
ted, from clean xylene in mounting medium. Microscopi-
cally, areas of immuno-reactivity were visualised as dark
brown staining, demonstrated by the DAB being oxidised.
Negative controls involved exception of the primary anti-
body stage. Fig. 1 demonstrates examples of haematoxylin
and eosin staining of aortic wall tissue (a), generic
lymphocyte immunohistochemistry (b, arrow) and negative
control (c), in serial sections cut from the same tissue block
(magnification 200).
Histological quantification
Quantification of the immunohistochemistry (IHC) staining
was undertaken using a Nikon E800 microscope with an
attached JVC KYF50 3 chip color video camera linked to an
Apple G3 computer through a Scion CG-7 frame grabber.
Images were analysed using the freeware package ‘NIH
Figure 1 Examples of (a) haematoxylin and eosin staining of aortic wall tissue, (b) generic lymphocyte immunohistochemistry
(arrow) and (c) negative control, in serial sections cut from the same tissue block (magnification 200).
Inflammation in Ruptured AAA 193Image’, automated by the use of in-house macros. In each
case the aortic adventitia was distinguished. Background
illuminationwas digitally subtracted fromeach image before
thresholding at a pre-set level which distinguished consis-
tently between stained and non-stained areas. A percentage
area fraction of immunostainingperfield areawas calculated
for each aneurysm biopsy from the mean of 10 images taken
over 5 stained sections.
Statistical analysis
Statistical analysis used GraphPad Prism 5. The continuous
variable, age was normally distributed, presented as
a mean (and standard deviation) and compared using the
unpaired t-test. Other continuous variables were non-nor-
mally distributed, reported as a median and interquartile
range (AAA diameter, inflammatory mediator levels and
cellular quantification data) and compared using the Man-
neWhitney U-test or Wilcoxon Paired test. Statistical
significance was assumed at the p< 0.05 level.
Results
Inflammatory mediator concentrations in non-
rupture site biopsies e non-ruptured AAA versus
ruptured AAA
There were no statistical differences in the median levels
of IL-6, IL-1b or TNF-a within non-rupture site biopsies from
ruptured and non-ruptured AAA (Table 1). These data
indicated there was no global increase in inflammatory
mediator concentration within the aneurysm sac prior to
rupture. A further analysis was therefore performed to
investigate any local differences within ruptured AAA
comparing the non-rupture site with the site of rupture.
Inflammatory mediator concentrations in ruptured
AAA e non-rupture site versus site of rupture
Table 2 details the biopsies of the non-rupture site and
rupture site within paired ruptured AAA. There were no
statistical differences in the concentrations of IL-6 and TNF-
abetween thepairedbiopsies. However,mean levels of IL-1b
were lower in biopsies from the site of aortic rupture
compared to the non-rupture site (IL-1b, 1.39ng/mg[0.97e2.29] vs. 1.92ng/mg [1.46e2.57], pZ 0.027). These
differences suggested that there was no localised up-regu-
lation of inflammation at the actual site of aortic rupture.
Histological analysis
Morphometric quantification of cellular content
Table 1 details the quantitative morphological data taken
from non-rupture site biopsies of non-ruptured and
ruptured AAA. Overall there was no difference in any
observed parameter with the percentage area fraction of
immunostaining for generic lymphocytes (CD-45), T-
lymphocytes (CD-3) and B-lymphocytes (CD-20) being
comparable between the groups. Table 2 shows the quan-
titative morphological data from ruptured AAA comparing
site of rupture versus non-rupture site biopsies from the
same ruptured AAA. The percentage area fraction of CD-45,
CD-3 and CD-20 were lower at the rupture site when
compared to non-rupture site biopsies from the same AAA
(generic lymphocytes 2.89% [0.51e5.51] vs. 4.73%
[2.27e12.40], pZ 0.018; T-cells 0.28% [0.04e1.18] vs.
0.82% [0.40e1.36], pZ 0.027; B-cells 0.16% [0.04e1.14] vs.
1.30% [0.32e5.40], pZ 0.021).Discussion
The present investigation demonstrated no elevation of
inflammatory cell andmediator concentrations between the
site of aneurysm rupture and a non-rupture area in the same
ruptured aneurysm or stable non-ruptured aneurysms.
Indeed, rather than a simple equilibrium, lymphocytes and
IL-1b appeared to be decreased at the site of rupture.
The exact role of lymphocytes in aneurysm rupture is
poorly understood. Our group previously demonstrated
comparablemacrophageandneutrophil content but reduced
lymphocyte (CD-45) levels at the rupture site compared with
a non-rupture site in ruptured aneurysms.4 Choke et al.
detailed increased neovascularisation at the site of aneu-
rysm rupture compared to a non-rupture site in the ruptured
aneurysm. Macrophages and lymphocytes were spatially
orientated around neo-vessels but there was no qualitative
increase in inflammatory cell content at the rupture site.3
Kazi et al. reported increased T-cell (CD-3) and B-cell (CD-
20) content in thrombus covered versus thrombus-free
aneurysmal wall. However, they could not show a difference
Table 1 Comparison of inflammatory mediator and lymphocyte concentrations in non-rupture site biopsies from non-ruptured
and ruptured abdominal aortic aneurysms (AAA). (Values shown as median and interquartile range, %Z percentage area
fraction of immunostaining per field, comparison used ManneWhitney U-test).
Non-ruptured site biopsies
Non-ruptured AAA (nZ 31) Ruptured AAA (nZ 20) p-value
Inflammatory mediators
IL-6 (ng/mg) 278.5 (237.9e421.9) 344.0 (265.9e516.3) 0.401
IL-1b (ng/mg) 2.16 (1.84e2.77) 2.09 (1.54e3.08) 0.446
TNF-a (ng/mg) 2.11(1.56e2.99) 2.31 (1.65e2.76) 0.931
Lymphocytes
Generic lymphocytes CD-45 (%) 4.46 (1.23e5.94) 4.73 (2.27e12.40) 0.638
T-cells CD-3 (%) 0.32 (0.03e0.87) 0.33 (0.15e0.68) 0.982
B-cells CD-20 (%) 0.89 (0.27e2.71) 0.99 (0.19e3.58) 0.894
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inflammation may occur at aneurysm inception but this
decreases in larger aneurysms.6 Duftner et al. described
higher levels of a specific subgroup of circulating T-cells (CD-
28(-)) in smaller aneurysms (<4 cm) than larger aneurysms.7
Humana et al. found greater macrophage expression in small
aneurysms than larger aneurysms.8
Animal models that rely on a preliminary chemical or
inflammatory stimulus for aneurysm growth are typified by
rapid aneurysm formation.9 Animal models suggest a role
for T-cells in aneurysmal vessel development. Xiong et al.
demonstrated resistance to aneurysm formation in CD4þ
and IFN-gamma gene knockout mice.10 Duftner et al.
showed that neutropaenia limited both the incidence and
size and aneurysm formation.7 It is probable the patho-
genesis of murine models are somewhat removed from the
slowly progressing human AAA. Resolution of these
dilemmas are challenging since animal models represent an
important surrogate for investigation and ethical and moral
issues limit what is feasible in human research.
Inflammatory mediators are critical to inflammatory cell
activation, adhesions and migration. A recent systematic
reviewofstudiesexamining inflammationassociatedcytokines
inaneurysmal tissuedescribed theelevatedexpressionofmost
inflammatory mediators in aneurysmal tissue compared to
normal controls.11 When comparing aneurysmal with athero-
sclerotic tissue, the pattern was less clear. Studies reportTable 2 Comparison of inflammatory mediator and lymphocyte
in paired non-rupture and ruptured site biopsies. (Values show
fraction of immunostaining per field, comparison used Wilcoxon
Paired bioposies form
Non-rupture site (nZ
Inflammatory mediators
IL-6 (ng/mg) 274.3 (192.2e504.6)
IL-1b (ng/mg) 1.92 (1.46e2.57)
TNF-a (ng/mg) 2.37 (1.64e3.15)
Lymphocytes
Generic lymphocytes CD-45 (%) 4.73 (2.27e12.40)
T-cells CD-3 (%) 0.82 (0.40e1.36)
B-cells CD-20 (%) 1.30 (0.32e5.40)contrasting results with increased, decreased or equivocal
levels of most inflammatorymediators including IL-1b and IL-6
in aneurysmal tissue compared with atherosclerotic aortic
samples. The most consistently elevated factors in larger
aneurysms were TNF-a and Interferon Gamma.11
Comparisons of inflammatory mediator levels in anterior
aneurysm sac biopsies of non-ruptured and ruptured aneu-
rysms have been conducted. However, there are no previous
reports describing the protein levels of inflammatory medi-
ators in tissue samples from the actual site of rupture. Cheuk
et al. described significantly elevated IL-6 levels in anterior
wall biopsies from ruptured AAA compared with non-
ruptured AAA but no difference in IL-1b, IL-8 and IL-10
concentrations.12 Treska et al. reported increased IL-6, IL-8
and TNF-a levels in anterior aneurysm sac biopsies of
ruptured AAA compared with non-ruptured AAA but no
difference in IL-1b concentrations.13 The present study
failed to show higher IL-6 levels in anterior aneurysm sac
biopsies of ruptured versus non-ruptured aneurysms since
a statistical difference could not be proved. By contrast, IL-
1b and TNF-a expression were comparable between sample
groups. Messenger RNA levels of IL-6 and IL-8 have been
assayed in rupture site tissue and demonstrated an elevation
compared tonon-ruptured site levels,14 but the failure of this
current study to observe an increase in IL-6 at protein level
serves to re-enforce the difference betweenmRNA and their
biological effecters, the protein.concentrations in ruptured abdominal aortic aneurysms (AAA)
n as median and interquartile range, %Z percentage area
paired test, p< 0.05, *Z significance).
ruptured AAA
12) Site of rupture (nZ 12) p-value
306.5 (200.7e466.7) 0.573
1.39 (0.97e2.29) 0.027
1.66 (0.88e2.71) 0.131
2.89 (0.51e5.51) 0.018*
0.28 (0.04e1.18) 0.027*
0.16 (0.04e1.14) 0.021*
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inflammatory cell subgroups may be up- or down-regulated
during aneurysm formation. We chose to avoid sub-classi-
fication. Rather we analysed whole populations of T-cells
(CD-3) and B-cells (CD-20) in order to observe general
inflammatory trends rather than specific changes in cellular
subsets. Secondly, aneurysm specimens were only available
from large AAA. All observational studies are limited by the
use of end-stage disease tissue to extrapolate early bio-
logical changes. Thirdly, the difference in aneurysm size
observed between the study groups may have confounded
some comparisons. However, the use of paired aortic
biopsies from the same patient reduced many of the
disadvantages of using clinical material.
The absolute significance of our findings is unclear. This
study serves only to document observations rather than offer
a mechanistic explanation for these changes. When
comparing a non-ruptured area to the actual site of rupture
in the same aneurysm, levels of MMP8 and MMP9 are dispro-
portionately elevated at the site of aneurysm rupture.4
Similar changes are noted with neovascularisation, with the
site of aneurysm rupture having greater numbers of imma-
ture neo-vessels. Logically one might also suspect inflam-
mation to be up-regulated at the site of rupture. However,
our consistent failure to observe such an increase, both in
this study and in previous work,3,4 may suggest otherwise.
In conclusion, this study poses many questions regarding
the role of inflammation in aneurysm biology. The findings
suggest the biological events leading to rupture may be
independent of an up-regulation in both inflammatory cell
infiltration and inflammatory cell expression.
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